|
|
Office Locations:
|
7550 Purple Sage
Park City, UT 84098
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Narrow River seeks to identify and license promising molecules that have been deprioritized by pharmaceutical companies and to develop them in indications with high medical need for which the current standard of care is inadequate. Staffed by experienced pharma and biotech clinicians, scientists and executives, Narrow River forms and manages the special purpose companies into which the compounds have been licensed.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
